Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database
- PMID: 17378910
- DOI: 10.1111/j.1572-0241.2007.01117.x
Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database
Abstract
Background: Available data on the prevalence of esophageal and upper gut findings in patients with noncardiac chest pain (NCCP) are scarce and limited to one center's experience.
Aim: To determine the prevalence of esophageal and upper gut mucosal findings in patients undergoing upper endoscopy for NCCP only versus those with gastroesophageal reflux disease (GERD) symptoms only, using the national Clinical Outcomes Research Initiative (CORI) database.
Methods: During the study period, the CORI database received endoscopic reports from a network of 76 community, university, and Veteran Administration Health Care System (VAHCS)/military practice sites. All adult patients who underwent an upper endoscopy for NCCP only or GERD-related symptoms only were identified. Demographic characteristics and prevalence of endoscopic findings were compared between the two groups.
Results: A total of 3,688 consecutive patients undergoing an upper endoscopy for NCCP and 32,981 for GERD were identified. Normal upper endoscopy was noted in 44.1% of NCCP patients versus 38.8% of those with GERD (P<0.0001). Of the NCCP group, 28.6% had a hiatal hernia (HH), 19.4% erosive esophagitis (EE), 4.4% Barrett's esophagus (BE), and 3.6% stricture/stenosis. However, HH, EE, and BE were significantly more common in the GERD group as compared with the NCCP group (44.8%, 27.8%, and 9.1%, respectively, P<0.0001). In univariate analysis of patients with NCCP, male gender was a risk factor for BE (OR 1.86, 95% CI 1.35-2.55, P=0.0001) and being nonwhite was protective (OR 0.43, 95% CI 0.22-0.86, P=0.02). In this group, male gender was also a risk factor for EE (OR 1.31, 95% CI 1.11-1.54, P=0.001) and age>or=65 yr was protective (OR 0.73, 95% CI 0.6-0.89, P=0.002). The NCCP group had a significantly higher prevalence of peptic ulcer in the upper gastrointestinal tract as compared with the GERD group (2.0% vs 1.5%, P=0.01).
Conclusions: In this endoscopic prevalence study, most of the endoscopic findings in NCCP were GERD related, but less common as compared with GERD patients.
Similar articles
-
Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.Am J Gastroenterol. 2009 Sep;104(9):2145-52. doi: 10.1038/ajg.2009.279. Epub 2009 Jun 9. Am J Gastroenterol. 2009. PMID: 19513020
-
The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.Am J Gastroenterol. 2002 Oct;97(10):2524-9. doi: 10.1111/j.1572-0241.2002.06034.x. Am J Gastroenterol. 2002. PMID: 12385433
-
Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study.J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):141-6. doi: 10.1097/MPG.0b013e31815eeabe. J Pediatr Gastroenterol Nutr. 2008. PMID: 18664864
-
Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis.Arch Intern Med. 2005 Jun 13;165(11):1222-8. doi: 10.1001/archinte.165.11.1222. Arch Intern Med. 2005. PMID: 15956000 Review.
-
How do we define non-cardiac chest pain?J Gastroenterol Hepatol. 2005 Dec;20 Suppl:S2-5. doi: 10.1111/j.1440-1746.2005.04164.x. J Gastroenterol Hepatol. 2005. PMID: 16359344 Review.
Cited by
-
Diagnosis and Management of Functional Chest Pain in the Rome IV Era.J Neurogastroenterol Motil. 2019 Oct 30;25(4):487-498. doi: 10.5056/jnm19146. J Neurogastroenterol Motil. 2019. PMID: 31587539 Free PMC article. Review.
-
Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis.Arch Surg. 2011 Jul;146(7):851-8. doi: 10.1001/archsurg.2011.174. Arch Surg. 2011. PMID: 21768433 Free PMC article.
-
Optimizing the Cost-Effective Evaluation of Gastroesophageal Reflux by Typical Symptom Phenotypes After Failure of Empiric Acid Suppression Trial.Am J Gastroenterol. 2025 Jun 5:10.14309/ajg.0000000000003576. doi: 10.14309/ajg.0000000000003576. Online ahead of print. Am J Gastroenterol. 2025. PMID: 40471840
-
How to Diagnose and Treat Functional Chest Pain.Curr Treat Options Gastroenterol. 2016 Dec;14(4):429-443. doi: 10.1007/s11938-016-0106-y. Curr Treat Options Gastroenterol. 2016. PMID: 27709331 Review.
-
Non-Cardiac Chest Pain: A Review of Environmental Exposure-Associated Comorbidities and Biomarkers.EMJ Gastroenterol. 2018 Dec;7(1):103-112. Epub 2018 Dec 11. EMJ Gastroenterol. 2018. PMID: 30774967 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical